EXELIXIS, INC. — Director's Dealing 2017

Mar 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-03-15

Reporting Person: Schwab Gisela (Pres Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-15	Common Stock	M	17707	$4.42	Acquired	175760	Direct
2017-03-15	Common Stock	M	32300	$7.18	Acquired	208060	Direct
2017-03-15	Common Stock	S	50007	$22.53	Disposed	158053	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-15	Option (right to buy)	$4.42	M	17707	Disposed	2019-02-25	Common Stock (17707.0)	Direct
2017-03-15	Option (right to buy)	$7.18	M	32300	Disposed	2019-12-08	Common Stock (32300.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13974	Indirect

Footnotes

F1: Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents 13,974 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 15, 2017.

F3: The option, representing the right to purchase a total of 25,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 26, 2013.

F4: The option, representing the right to purchase a total of 210,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013.